Symbol="ESPR"
AssetType="Common Stock"
Name="Esperion Therapeutics Inc"
Description="Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan."
CIK="1434868"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="144910000"
EBITDA="-184688992"
PERatio="None"
PEGRatio="-4.78"
BookValue="-3.779"
DividendPerShare="0"
DividendYield="0"
EPS="-3.23"
RevenuePerShareTTM="1.144"
ProfitMargin="-2.947"
OperatingMarginTTM="-2.286"
ReturnOnAssetsTTM="-0.389"
ReturnOnEquityTTM="-2.608"
RevenueTTM="80968000"
GrossProfitTTM="-70419000"
DilutedEPSTTM="-3.23"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.292"
AnalystTargetPrice="10.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.98"
PriceToBookRatio="98.42"
EVToRevenue="6.93"
EVToEBITDA="-2.675"
Beta="0.135"
num_52WeekHigh="8.87"
num_52WeekLow="1.12"
num_50DayMovingAverage="1.457"
num_200DayMovingAverage="4.215"
SharesOutstanding="94713000"
DividendDate="None"
ExDividendDate="None"
symbol="ESPR"
open="1.42"
high="1.54"
low="1.40"
price="1.53"
volume="1795647.00"
latest_trading_day="2023-07-28"
previous_close="1.39"
change="0.14"
change_percent="10.0719%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="79"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="3413460"
Change_recent_avg="-0.02"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_negative_thumbnail_id_2="1093"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="611"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0097.jpeg"
image_positive_thumbnail_id_2="1000"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
